Equine TIMP-1 and TIMP-2: identification, activity and cellular sources

Area of Science:

• Equine Medicine
• Biochemistry
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs) regulate connective tissue turnover.
• Tissue inhibitors of metalloproteinases (TIMPs) control MMP activity.
• Understanding TIMPs in equine joints is crucial for diagnosing and treating joint diseases.

Purpose of the Study:

• To assess the presence and activity of TIMPs in equine synovial fluid.
• To determine the cellular sources of TIMPs in equine articular tissues.
• To characterize TIMPs involved in equine joint homeostasis and disease.

Main Methods:

• Gelatin degradation ELISA to measure MMP-9 inhibition by synovial fluid.
• Cell culture of chondrocytes, synovial fibroblasts, polymorph neutrophils (PMNs), and peripheral blood monocytes (PBMs).
• Reverse zymography, affinity chromatography, and N-terminal amino acid sequencing to characterize TIMPs.

Main Results:

• TIMP activity was minimal in articular sepsis but increased in aseptic joint disease (AJD) compared to normal horses.
• Synovial fibroblasts, chondrocytes, and PBMs produced TIMPs; PMNs did not.
• Reverse zymography identified 22 kDa and 28 kDa TIMP bands in synovial fluid and cell cultures, with the 22 kDa band showing homology to human TIMP-2.

Conclusions:

• TIMPs are present in equine synovial fluid and produced by articular cells.
• TIMPs play a role in maintaining normal joint homeostasis.
• Altered TIMP levels may contribute to the excessive proteolysis observed in equine articular diseases.